Robotic Lung Biopsy Market Detail Analysis of Current and Future Projection 2023 to 2033

The global Robotic Lung Biopsy Market Sales value is expected to increase from US$ 408.0 Million in 2023 to US$ 1,023.05 Million by 2033. Over the next decade (2023 to 2033), global Robotic Lung Biopsy demand is forecast to surge at 9.6% CAGR.

The Robotic Lung Biopsy industry is driven by several factors. This includes the minimally invasive nature of robotic lung biopsies, the growing demand for personalized medicine, and the increasing prevalence of lung cancer.

Robotic Lung Biopsy refers to a minimally invasive procedure performed using robotic-assisted technology to obtain tissue samples from the lungs for diagnostic purposes. It involves the use of a robotic system, typically controlled by a surgeon, to guide the biopsy needle to the targeted lung lesion.

During a Robotic Lung Biopsy, the patient is placed under general anesthesia. The surgeon makes small incisions in the chest, through which robotic arms with specialized instruments and a camera are inserted. The surgeon controls the robotic system from a console, manipulating the instruments with precision and accuracy.

Lung cancer is one of the leading causes of cancer-related deaths worldwide. As the incidence of lung cancer continues to rise, there is a growing demand for advanced diagnostic and treatment methods. This includes Robotic Lung Biopsy, which can accurately diagnose lung tumors and guide treatment decisions.

Robotic Lung Biopsy procedures are minimally invasive compared to open surgical biopsies. They involve smaller incisions, reduced trauma to the patient, and faster recovery times. This less invasive approach appeals to both patients and healthcare providers, leading to increased adoption of Robotic Lung Biopsy techniques.

There is also a growing focus on personalized medicine, which aims to provide tailored treatment options based on individual patient characteristics. Robotic Lung Biopsy plays a crucial role in obtaining tissue samples for molecular testing, which helps identify specific genetic mutations or biomarkers that can guide targeted therapies.

Key Players in the Robotic Lung Biopsy Industry

  • Ethicon, Inc. (Johnson & Johnson)
  • Intuitive Surgical

Get More Insights@ https://www.futuremarketinsights.com/reports/robotic-lung-biopsy-market

Robotic Lung Biopsy Market Segmentation

By Product and Services:

  • System
  • Instruments and Accessories
  • Service

By Navigation Technology:

  • Electromagnetic and Optical Navigation
  • Fiber Optic RealShape Navigation

By End User:

  • Hospitals
  • Ambulatory Surgical Centers

Comments

Post a Comment

Popular posts from this blog

Handheld Ultrasound Scanners Market Will Generate Booming Growth Opportunities to 2032

Image
According to industry predictions, the global Handheld Ultrasound Scanners Market Demand will increase at a CAGR of 9.1% from 2022 to 2032, reaching a value of US$ 472.1 million by the end of 2022. By 2032, sales are estimated to exceed a valuation of roughly US$ 1.1 billion. With an expected 83.6% market share in 2021, the wired modality now leads the sector. Because they connect to Bluetooth or Wi-Fi devices such as mobile phones or tablets, Handheld Ultrasound Scanners are gaining appeal among both medical professionals and non-radiologists. These devices improve networking systems and ease picture transfer to medical facilities. Global Handheld Ultrasound Scanners Market: Dynamics         Technological advancements in medical imaging devices, increased use of Handheld Ultrasound Scanners among non-radiologists, benefits from international trade agreements, increased importing of imaging diagnostics systems, increased use of Handheld Ultrasound Scanners in emergency medical service
Read more

Targeted Therapies for Sandhoff Disease | Assessing the Global Market Landscape

Image
The global Sandhoff Disease Therapeutics Market Size is expected to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. From 2018 to 2022, the Sandhoff Disease Treatments market increased at a 4% CAGR. According to the most recent studies, Sandhoff sickness is a rare disorder that affects 1 in 1,000,000 people. The rising demand for these medications is projected to spur the discovery of novel therapies, propelling the market forward in the coming years. Gene therapy is being investigated as a potential treatment for Sandhoff disease. The therapy restores the ability to break down GM2 ganglioside by delivering a functional copy of the missing enzyme into the patient's cells. This has the potential to reduce or stop disease progression while also improving patient quality of life. Key Takeaways from the Market Study   The Sandhoff Disease Therapeutics market increased at a 4% CAGR from 2018 to 2022. From 2023 to 2033, the global Sandh
Read more

Antidiabetics Market to reach US$ 223 billion by 2032, growing at a 9.6% CAGR from 2022 to 2032 | Future Market Insights, Inc.

Image
The global Antidiabetics Market is expected to earn US$ 223 billion while expanding at a CAGR of 9.6% during the forecast period. The rising prevalence of diabetes worldwide can be attributed to the market's expansion. The ageing baby boomer population is another factor driving the market during the forecast period. According to the International Diabetes Federation, the global diabetes incidence will increase from 366 million in 2011 to 552 million by 2030. During the forecast period, the industry is expected to benefit from a significant increase in the number of diabetic patients. Furthermore, new product development is expected to benefit the market in the near future. For example, Novo Nordisk, a Danish pharmaceutical company, announced the launch of oral semaglutide for the treatment of Type 2 diabetes in India in January 2022. Furthermore, the development of advanced pumps based on smart technologies like AI and ML is expected to open up a slew of new doors. For exampl
Read more